According to Bloomberg News, Vinay Prasad, who oversees gene therapies at the FDA, said the plans will be published in early November. He foresees the approach sparking curiosity for the next wave of ...

"We do really have to give President ... But if you want to use CRISPR for gene therapy, you must first get the scissors, as ...

Cathy Tie, who launched her first biotech in SF's IndieBio, now leads Manhattan Genomics in controversial push to edit human ...

The Boston biotech founded by Harvard professor David Sinclair is testing whether cellular reprogramming can turn back the ...

Seven years after the first gene-edited babies were revealed, biotech startup Manhattan Genomics is reviving the idea of ...

Manhattan Genomics is advancing next-generation medical technologies to correct harmful mutations at the embryonic stage. The company's singular mission is to prevent severe inherited conditions, such ...

CAR T-cell therapy uses re-engineered immune cells to attack diseases. After proving its effectiveness on cancer patients, it ...

This insightful review explores key areas of cancer genetic research, focusing on genes that may benefit from ...

In 1962, a pediatric neurology resident at Columbia's Neurological Institute and his colleagues in the College of Physicians ...

As flu season approaches and public health officials roll out their annual push for vaccination, Allen Institute scientists ...

Liver cells are indispensable for research—for drug testing, to better understand diseases such as hepatitis, fatty liver, cirrhosis, or liver cancer and for development of future cell therapies.

We are now in the second great wave of the genetic revolution, not defined by reading the human code of life, but by rewriting it.